AGP Picks
View all

Wolf Popper LLP Announces Investigation on Behalf of BillionToOne, Inc. Investors

News originally published by

GlobeNewswire

NEW YORK, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of BillionToOne, Inc. (BillionToONe) common stock (NASDAQ: BLLN).

BillionToOne provides genetic testing and recently held its initial public offering on November 5 2025 at $60.00 per share.

Before the market opened on November 18, 2026, short seller Fuzzy Panda Research published a report entitled BillionToOne (BLLN) – Undisclosed Fraudulent Billing Allegations; Deductible Capping Scheme Formers Say is “Against the Law;” Dr’s Debunk Oncology Hype. The report alleges multiple issues including BillionToOne hasn’t disclosed Tennessee is investigating the company for Medicaid fraud, BillionToOne bills insurers for tests the pregnant women don’t need, BillionToOne reduces or eliminates deductibles and copays to encourage doctors and patients to use its test, and BillionToOne overpays doctors for blood draws and supplies free phlebotomists who also perform unrelated work. On that news, BillionToOne’s stock price fell $5.96 per share to $91.54, down 6.1% on heavy volume.

Investors who suffered losses trading in BillionToOne common stock and who would like to discuss the investigation should contact Adam Savett at (212) 451-9655, or asavett@wolfpopper.com.

Wolf Popper has successfully recovered billions of dollars for defrauded investors. Wolf Popper’s reputation and expertise have been repeatedly recognized by courts that have appointed the firm to major positions in securities litigation. For more information about Wolf Popper, please visit the Firm’s website at www.wolfpopper.com.

May Be Considered Attorney Advertising in Certain Jurisdictions.
Prior Results Do Not Guarantee a Similar Outcome.

Wolf Popper LLP
Adam Savett. Esq.
570 Lexington Avenue
New York, NY 10022
Tel.: (212) 451-9655
Email: asavett@wolfpopper.com 


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Djibouti Business Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.